Germline testing for predisposition to ovarian/breast cancer should be routinely recommended in all patients with invasive epithelial ovarian cancer

被引:0
|
作者
Wheeler L.J. [1 ]
Guntupalli S. [1 ]
机构
[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, School of Medicine, Anschutz Medical Campus, 12631 East 17th Avenue B198-6, Aurora, 80045, CO
关键词
Genetic testing; Ovarian cancer; Universal screening;
D O I
10.1007/s40944-017-0164-7
中图分类号
学科分类号
摘要
Given the marked prevalence of germline mutations among women with ovarian cancer, we recommend universal BRCA genetic screening, regardless of patient age or family history. © Association of Gynecologic Oncologists of India 2017.
引用
收藏
页码:S27 / S30
页数:3
相关论文
共 50 条
  • [41] Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer
    Velazquez, Carolina
    De Leeneer, K.
    Esteban-Cardenosa, Eva M.
    Avila Cobos, Francisco
    Lastra, Enrique
    Abella, Luis E.
    de la Cruz, Virginia
    Lobaton, Carmen D.
    Claes, Kathleen B.
    Duran, Mercedes
    Infante, Mar
    CANCERS, 2020, 12 (08) : 1 - 17
  • [42] Survival among US women with invasive epithelial ovarian cancer
    McGuire, V
    Jesser, CA
    Whittemore, AS
    GYNECOLOGIC ONCOLOGY, 2002, 84 (03) : 399 - 403
  • [43] Quality of life for patients with epithelial ovarian cancer
    Sun, Charlotte C.
    Ramirez, Pedro T.
    Bodurka, Diane C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (01): : 18 - 29
  • [44] Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
    Herold, Natalie
    Schmolling, Johanna
    Ernst, Corinna
    Ataseven, Beyhan
    Bluemcke, Britta
    Schoemig-Markiefka, Birgid
    Heikaus, Sebastian
    Goehring, Uwe-Jochen
    Engel, Christoph
    Lampe, Bjoern
    Rhiem, Kerstin
    Harter, Philipp
    Hauke, Jan
    Schmutzler, Rita K.
    Hahnen, Eric
    CANCER MEDICINE, 2023, 12 (14): : 15256 - 15260
  • [45] Germline Screening of Cancer-Related Genes in Turkish Ovarian Cancer Patients
    Ates, Esra Arslan
    Alavanda, Ceren
    Geckinli, Bilgen Bilge
    Guney, Ahmet Ilter
    Gunel, Tuba
    EXPERIMED, 2022, 12 (03): : 181 - 187
  • [46] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Lerner-Ellis, Jordan
    Mighton, Chloe
    Lazaro, Conxi
    Watkins, Nicholas
    Di Gioacchino, Vanessa
    Wong, Andrew
    Chang, Martin C.
    Charames, George S.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 871 - 879
  • [47] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Jordan Lerner-Ellis
    Chloe Mighton
    Conxi Lazaro
    Nicholas Watkins
    Vanessa Di Gioacchino
    Andrew Wong
    Martin C. Chang
    George S. Charames
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 871 - 879
  • [48] Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients
    DeLeonardis, Kimberly
    Sedgwick, Kristin
    Voznesensky, Olga
    Matloff, Ellen
    Hofstatter, Erin
    Balk, Steven
    Tung, Nadine
    BREAST JOURNAL, 2017, 23 (04) : 461 - 464
  • [49] Same day service: A genetic testing station model to improve germline genetic testing in patients with ovarian cancer
    Marjon, Nicole
    Guerra, Rosa
    Freeman, Alexandra
    Mak, Julie
    Cheung, Stephanie
    Gordon, Kelly
    Blanco, Amie
    Ueda, Stefanie
    Chen, Lee-may
    GYNECOLOGIC ONCOLOGY, 2023, 177 : 53 - 59
  • [50] Ovarian Cancer Patients' Search for Genetic Testing Information on the Internet
    Yi, Siqi
    Zhang, Yan
    Trace, Ciaran B.
    Williams-Brown, Marian Yvette
    CHIIR'22: PROCEEDINGS OF THE 2022 CONFERENCE ON HUMAN INFORMATION INTERACTION AND RETRIEVAL, 2022, : 295 - 299